Study of why people join PRADO and telemedicine for heart failure
Part of Heart & circulation clinical trials.
This study looks at what influences whether people with heart failure choose to join PRADO and telemedicine support after a hospital stay. Your answers can help the team understand barriers and improve future participation and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18+).
- You are currently in the hospital, or you were admitted because your heart failure strongly contributed to the reason you were admitted.
- A clinician agrees that heart failure is a key part of why you were admitted.
- You are willing to participate and do not object to the research.
- You are not pregnant or breastfeeding.
- You can give consent yourself (or have a protected adult consent process), and you are not considered a vulnerable person by the study rules; you are not in custody or otherwise deprived of liberty.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to diagnose heart failure in people over 60 living in rural areas using telemedicine and remote lab tests. It may help find heart failure earlier and reduce hospital visits.
This trial tests a new way of caring for heart failure that combines in-person clinic visits with at-home monitoring using digital tools. If you join, you may be able to have more of your check-ups from home, which could be more convenient and help your care team catch problems early.
This study tests a remote health support program for adults with heart failure who may have palliative care needs. It aims to see if the program can help manage symptoms and reduce hospital visits. Caregivers and healthcare professionals are also involved.
This study follows adults with chronic or newly diagnosed heart failure to learn how patients do after they leave the hospital, mainly while taking heart medicines by mouth. It may help researchers better understand which patients have different outcomes and needs.
This study tests a virtual ward program for people recently hospitalized with heart failure. It aims to see if monitoring and support at home can improve recovery and quality of life.
This trial looks at how well a telemonitoring program works for people with heart failure. It checks if the eligibility rules used by the French health authority make sense.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.